1.Research progress of thyroid hormone in pulmonary fibrosis.
Bao Yan LIU ; Yong WANG ; Yan LIU ; Juan LI ; Ping CUI ; Jin HE
Chinese Journal of Industrial Hygiene and Occupational Diseases 2023;41(1):62-66
Pulmonary fibrosis is end-stage of variety of heterogeneous interstitial lung disease, characterizedby excessive proliferation of fibroblasts and extracellular matrix deposition and destruction of lung parenchyma. Thyroid and lung are derived from the same endodermal cells, thyroid hormone affect the occurrence、development and prognosis of the chronic obstructive pulmonary disease, lung cancer and other lung diseases, This article reviews the role and mechanism of thyroid hormone in pulmonary fibrosis in order to provide new idea for the study of the role and mechanism of thyroid hormone in silicosis.
Humans
;
Pulmonary Fibrosis/pathology*
;
Lung/pathology*
;
Silicosis
;
Lung Diseases, Interstitial
;
Fibroblasts
;
Thyroid Hormones
;
Fibrosis
2.Single-cell profiling reveals Müller glia coordinate retinal intercellular communication during light/dark adaptation via thyroid hormone signaling.
Min WEI ; Yanping SUN ; Shouzhen LI ; Yunuo CHEN ; Longfei LI ; Minghao FANG ; Ronghua SHI ; Dali TONG ; Jutao CHEN ; Yuqian MA ; Kun QU ; Mei ZHANG ; Tian XUE
Protein & Cell 2023;14(8):603-617
Light adaptation enables the vertebrate visual system to operate over a wide range of ambient illumination. Regulation of phototransduction in photoreceptors is considered a major mechanism underlying light adaptation. However, various types of neurons and glial cells exist in the retina, and whether and how all retinal cells interact to adapt to light/dark conditions at the cellular and molecular levels requires systematic investigation. Therefore, we utilized single-cell RNA sequencing to dissect retinal cell-type-specific transcriptomes during light/dark adaptation in mice. The results demonstrated that, in addition to photoreceptors, other retinal cell types also showed dynamic molecular changes and specifically enriched signaling pathways under light/dark adaptation. Importantly, Müller glial cells (MGs) were identified as hub cells for intercellular interactions, displaying complex cell‒cell communication with other retinal cells. Furthermore, light increased the transcription of the deiodinase Dio2 in MGs, which converted thyroxine (T4) to active triiodothyronine (T3). Subsequently, light increased T3 levels and regulated mitochondrial respiration in retinal cells in response to light conditions. As cones specifically express the thyroid hormone receptor Thrb, they responded to the increase in T3 by adjusting light responsiveness. Loss of the expression of Dio2 specifically in MGs decreased the light responsive ability of cones. These results suggest that retinal cells display global transcriptional changes under light/dark adaptation and that MGs coordinate intercellular communication during light/dark adaptation via thyroid hormone signaling.
Animals
;
Mice
;
Dark Adaptation
;
Light
;
Retina
;
Retinal Cone Photoreceptor Cells/metabolism*
;
Adaptation, Ocular
;
Neuroglia/physiology*
;
Cell Communication
;
Thyroid Hormones
3.Research progress on the relationship between liver cirrhosis and thyroid hormones.
Ming Yun ZHENG ; Ya Jun HE ; Xu You LIU ; Qing Hui ZHANG ; Teng Yan WANG ; Jie Lun YANG ; Jian Chang SHU
Chinese Journal of Hepatology 2022;30(3):331-334
There exists a complex relationship between liver and thyroid hormones. Liver plays an important role in the activation, inactivation, transportation, and metabolism of thyroid hormones. At the same time, thyroid hormones also affect hepatocytes activity and liver metabolism, such as lipid and bilirubin metabolism. Importantly, thyroid hormone levels often change abnormally in patients with liver cirrhosis. Therefore, studying the change of thyroid hormone levels in patients with liver cirrhosis has a certain clinical value for assessing the severity, prognosis, diagnosis and treatment. This paper reviews the research progress on the relationship between liver cirrhosis and thyroid hormone.
Bilirubin
;
Humans
;
Liver/metabolism*
;
Liver Cirrhosis/metabolism*
;
Thyroid Hormones/metabolism*
4.Association between thyroid hormone levels and frailty in the community-dwelling oldest-old: a cross-sectional study.
Bo GUAN ; Jiakun LUO ; Xin HUANG ; Fan TIAN ; Shasha SUN ; Yufei MA ; Yan YU ; Ruihan LIU ; Jian CAO ; Li FAN
Chinese Medical Journal 2022;135(16):1962-1968
BACKGROUND:
Changes in thyroid hormone levels are commonly recognized characters among the elderly, which were reported to potentially influence incident frailty. Therefore, we examined the cross-sectional associations of thyroid hormones (THs) with frailty as well as the five components characterizing frailty (fatigue, resistance, ambulation, number of illnesses, and loss of weight) among the oldest-old.
METHODS:
Four hundred and eighty-seven community-dwelling oldest-old from a local community in Haidian District, Beijing, participated in our recruitment campaign between April 2019 and May 2020. The primary outcomes were a definitive diagnosis of frailty according to the FRAIL scale (Fatigue, Resistance, Ambulation, Illnesses, Loss of weight) and a positive score for each frailty subdomain. Demographic information (age, sex, marital status, and educational status), comorbidities, and details on the participants' lifestyles were recorded. Serum THs including free triiodothyronin (fT3), triiodothyronine (T3), free thyroxine (fT4), and thyroxine (T4) and thyroid stimulating hormone (TSH) levels were also measured at the beginning of our study. Logistic regressions were conducted to screen for potential risk factors for frailty and its subdomains.
RESULTS:
Among the total 487 subjects at enrollment, 60 (12.23%) of them were diagnosed with subclinical hypothyroidism and 110 (22.59%) of the total population scored positive for frailty. Logistic regression analyses adjusted for all potential confounders, showed that frailty was significantly associated with the serum TSH concentration (odds ratio [OR]: 1.06), fT3 concentration (OR: 0.54), and subclinical hypothyroidism score (OR: 2.18). The association between fT4 and frailty was absent in our observational study. The fT3/fT4 ratio characterizing peripheral hormone conversion was also tested to be correlated with frailty.
CONCLUSION
Subclinical hypothyroidism, higher TSH level, lower fT3 level, and decreased fT3/fT4 ratio were all associated with frailty assessed by the FRAIL scale among the community-dwelling oldest-old, suggesting a relevant role of thyroid function in aging. Future longitudinal studies are warranted to determine the casual relationship between thyroid dysfunction and frailty in the oldest-old.
Humans
;
Aged, 80 and over
;
Aged
;
Thyroxine
;
Cross-Sectional Studies
;
Thyrotropin
;
Frailty
;
Independent Living
;
Triiodothyronine
;
Thyroid Function Tests
;
Thyroid Hormones
;
Hypothyroidism
;
Fatigue
5.Research advances on common detection biomarkers and methodology of children's growth and development assessment.
Chinese Journal of Preventive Medicine 2022;56(9):1211-1217
With the rapid dissemination of information in modern society, Chinese residents pay more attention to the scientific concept of childcare, which makes the child prevention and health care industry develop rapidly. The law of children's growth and development is extremely complex, so it is necessary to detect different biomarkers according to different growth and development evaluation angles. Human growth hormone(hGH), insulin-like growth factor-1(IGF-1), insulin-like growth factor binding protein-3(IGFBP-3), thyroid hormone, sex hormone, anti-müllerian hormone(AMH) and 25-hydroxy vitamin D(25-OH VD) are common biomarkers to monitor children's growth and development. This article aims to explain the concept and characteristics of common biomarkers of growth and development, summarize the detection methods of common biomarkers of growth and development evaluation developed in recent years, and provide a reference for children's prevention and health care to select appropriate detection biomarkers.
Anti-Mullerian Hormone/metabolism*
;
Biomarkers
;
Child
;
Growth and Development
;
Human Growth Hormone/metabolism*
;
Humans
;
Insulin-Like Growth Factor Binding Protein 3
;
Insulin-Like Growth Factor I/metabolism*
;
Thyroid Hormones
;
Vitamin D
6.Occupational Radiation Exposure and Changes in Thyroid Hormones in a Cohort of Chinese Medical Radiation Workers.
Qi Shan GUO ; Ping RUAN ; Wei Xu HUANG ; Dai Zheng HUANG ; Jia Chu QIU
Biomedical and Environmental Sciences 2021;34(4):282-289
Objective:
This study aimed to evaluate the association between occupational radiation exposure and changes in thyroid hormone levels among medical radiation workers.
Methods:
This retrospective cohort study included 2,946 radiation workers from 20 Guangzhou hospitals. Data on general characteristics, participant radiation dosimetry, and thyroid function test results [thyroid-stimulating hormone (TSH), triiodothyronine (T3), and thyroid hormone (T4)] were extracted from dosimetry and medical records. The generalized estimating equation was used to evaluate the trend of changes in thyroid hormone levels over time and was adjusted for age, gender, and occupation.
Results:
The average annual effective dose was very low and showed a general downward trend. During the follow-up period, changes in T3 and T4 levels among radiation workers were -0.015 [95% confidence interval (
Conclusion
Thyroid hormone secretion might be affected even in low-dose radiation exposure environments.
Adult
;
China
;
Cohort Studies
;
Female
;
Humans
;
Male
;
Middle Aged
;
Occupational Exposure/adverse effects*
;
Radiation Exposure/adverse effects*
;
Retrospective Studies
;
Thyroid Hormones/radiation effects*
;
Young Adult
7.Weekly versus daily Levothyroxine Tablet Replacement in Adults with Hypothyroidism: A meta-analysis
Harold Henrison Chiu ; Ramon Larrazabal Jr. ; Angelique Bea Uy ; Cecilia Jimeno
Journal of the ASEAN Federation of Endocrine Societies 2021;36(2):156-160
Objectives:
Daily levothyroxine is the treatment of choice and standard of care in hypothyroidism, sufficient to restore thyroid stimulating hormone (TSH) to normal range. For many patients, daily lifelong therapy is required, making adherence a major issue. In such cases, weekly replacement may be a suitable alternative to improve adherence. In this study, we aimed to determine the efficacy and safety of weekly levothyroxine replacement among adults with hypothyroidism.
Methodology:
Electronic databases were searched. Two reviewers (HCC and RBL) independently screened the abstracts, reviewed full-text papers, critically appraised the quality of included studies using PRISMA guidelines. Meta-analysis was performed using the random-effects model. The primary outcome is the difference in serum TSH levels between weekly and daily administration, while secondary outcomes included adverse events and symptoms of hypothyroidism.
Results:
The primary outcome is the difference in serum TSH levels between weekly and daily administration. Secondary outcomes included adverse events and clinical symptoms. The study included two randomized trials (n=109) in the primary analysis. The difference in TSH levels was 1.78 mIU/mL higher [(95% confidence interval (CI): 1.28 to 2.28, p<0.00001] at 6 weeks and 1.22 mIU/mL higher (95% CI: 0.76 to 1.67, p<0.00001) at 12 weeks for the weekly regimen. There was no significant heterogeneity between the two groups. There was no significant difference in hypothyroid symptoms and adverse events before and after levothyroxine treatment within each group.
Conclusions
Weekly levothyroxine resulted in less suppression and higher mean serum TSH levels, while still remaining within the normal reference range. It may be a suitable alternative for non-adherent patients. However, larger randomized trials with longer duration of follow-up are needed to firmly establish its role.
Hypothyroidism
;
Thyroxine
;
Thyroid Hormones
8.Comparison of Thyroid Hormones in Euthyroid Athyreotic Patients Treated with Levothyroxine and Euthyroid Healthy Subjects
Min Ji JEON ; Suk Hyun LEE ; Jong Jin LEE ; Min Kyu HAN ; Hong Kyu KIM ; Won Gu KIM ; Tae Yong KIM ; Won Bae KIM ; Young Kee SHONG ; Jin Sook RYU
International Journal of Thyroidology 2019;12(1):28-34
BACKGROUND AND OBJECTIVES: Levothyroxine (L-T4) monotherapy to normalize TSH level might be not sufficient to restore serum free triiodothyronine (fT3) levels in hypothyroid patients. This study aimed to compare the thyroid hormone levels in euthyroid L-T4 treated athyreotic patients and euthyroid healthy control subjects. MATERIALS AND METHODS: We included 69 euthyroid L-T4 treated athyreotic female patients after total thyroidectomy and radioactive iodine ablation therapy and 90 euthyroid healthy female. Serum fT3 and free thyroxine (fT4) levels were simultaneously measured using two different assay kits (A and B). RESULTS: The serum fT4 level was higher in the athyreotic patients (kit A: p<0.001, kit B: p=0.046), and the serum fT3 level was higher in control subjects (kit A: p=0.047, kit B: p=0.102). In the control group, the serum fT3 level was stable and not correlated with the TSH level (kit A: tau=−0.10, p=0.18, kit B: tau=−0.06, p=0.40). However, in the patient group, the serum fT3 level was negatively correlated with the TSH level (kit A: tau=−0.22, p=0.012, kit B: tau=−0.31, p<0.001). All thyroid hormone parameters measured by kit A showed higher area under the curve values than those measured by kit B for distinguishing the patients from the control subjects. CONCLUSION: The serum fT3 levels in L-T4 treated athyreotic euthyroid patients were significantly lower than and varied from those of euthyroid healthy control subjects. Thus, L-T4 monotherapy might not be appropriate for some athyreotic patients to maintain optimal T3 levels.
Female
;
Healthy Volunteers
;
Humans
;
Iodine
;
Thyroid Gland
;
Thyroid Hormones
;
Thyroidectomy
;
Thyroxine
;
Triiodothyronine
9.Association between Thyroid Dysfunction and Severity, Treatment Response in Schizophrenic Inpatients
Mee Jool JUNG ; Hyun Kuk HWANG ; Yung Eun SEO ; Jong Hyuk CHOI
Journal of the Korean Society of Biological Psychiatry 2019;26(1):14-21
OBJECTIVES: Thyroid hormone deficiency during the neurodevelopmental period can impair brain development and induce psychiatric symptoms. This study examined the association between thyroid dysfunction and the severity of symptoms in schizophrenia patients, and the treatment response of patients with schizophrenia. METHODS: Three hundred thirty-eight schizophrenia patients, with no prior history of thyroid disease or taking medication associated with it, were studied. We assessed the blood thyroid hormone level, the Brief Psychiatric Rating Scale (BPRS) scores on the day of admission and discharge, admission period, dose of administered antipsychotics, and the number of antipsychotic combinations. The collected data were subsequently analyzed using the Kruskal-Wallis test and Pearson's chi-square test. RESULTS: The percentage of schizophrenia patients who presented with abnormal thyroid hormone level was 24.6%. High total triiodothyronine (TT3) (p = 0.003), low TT3 (p = 0.001), and high free thyroxine (fT4) (p < 0.001) groups showed a higher BPRS score on admission than did the normal thyroid hormone group, while thyroid stimulating hormone (TSH) levels were not significantly correlated with the severity of symptoms. Furthermore, thyroid hormone was not associated with the treatment response assessed by the rate of BPRS score reduction, admission days, use of clozapine, and dose of antipsychotics. CONCLUSIONS: The TT3 and fT4 hormone levels were significantly associated with the severity of symptoms in schizophrenia patients. These relations suggested that thyroid dysfunction may be associated with the severity of schizophrenia. And hence, further analysis of the results of the thyroid function test, which is commonly used in cases of psychiatric admission, is required.
Antipsychotic Agents
;
Brain
;
Brief Psychiatric Rating Scale
;
Clozapine
;
Humans
;
Inpatients
;
Schizophrenia
;
Thyroid Diseases
;
Thyroid Function Tests
;
Thyroid Gland
;
Thyroid Hormones
;
Thyrotropin
;
Thyroxine
;
Triiodothyronine
10.The Relationship between Thyroid Function and Different Obesity Phenotypes in Korean Euthyroid Adults
Jeong Mi KIM ; Bo Hyun KIM ; Hyungi LEE ; Eun Heui KIM ; Mijin KIM ; Jong Ho KIM ; Yun Kyung JEON ; Sang Soo KIM ; In Joo KIM ; Yong Ki KIM
Diabetes & Metabolism Journal 2019;43(6):867-878
BACKGROUND: Thyroid disease and metabolic syndrome are both associated with cardiovascular disease. The aim of this study was to investigate the correlation between thyroid hormones and obesity sub-phenotypes using nationwide data from Korea, a country known to be iodine replete.METHODS: This study was based on data obtained from the sixth Korea National Health and Nutrition Examination Survey, administered from 2013 to 2015. A total of 13,873 participants aged ≥19 years were included, and classified into four groups: metabolically healthy non-obesity (MHNO), metabolically healthy obesity (MHO), metabolically unhealthy non-obesity (MUNO), and metabolically unhealthy obesity (MUO) by body fat on the basis of body mass index and metabolic health.RESULTS: At baseline, serum free thyroxine (fT4) values were significantly higher in the MHNO phenotype (MHNO, 1.27±0.01 ng/dL; MHO, 1.25±0.01 ng/dL; MUNO, 1.24±0.01 ng/dL; MUO, 1.24±0.01 ng/dL, P<0.001) in total study population. However, this significant association no longer remained after adjustment for age, urine iodine concentration, and smoking (P=0.085). After adjustment for confounders, statistically significant association was observed between lower thyroid stimulating hormone (TSH) and MHNO phenotype (P=0.044). In men participants (not women), higher fT4 values were significantly associated with MHNO phenotype (P<0.001). However, no significant association was observed between thyroid function (TSH or fT4) and obesity phenotypes in groups classified by age (cutoff age of 55 years).CONCLUSION: Although there was a difference by age and sex, we found that the decrease of TSH and the increase of fT4 values were associated with MHNO.
Adipose Tissue
;
Adult
;
Body Mass Index
;
Cardiovascular Diseases
;
Humans
;
Iodine
;
Korea
;
Male
;
Nutrition Surveys
;
Obesity
;
Obesity, Metabolically Benign
;
Phenotype
;
Smoke
;
Smoking
;
Thyroid Diseases
;
Thyroid Gland
;
Thyroid Hormones
;
Thyrotropin
;
Thyroxine


Result Analysis
Print
Save
E-mail